Logo
x

Search

Subscribe Now

Hospitalized Patients

Lilly and Incyte Report Results of Baricitinib in P-III COV-BARRIER Study for Hospitalized Patients with COVID-19

Lilly and Incyte Report Results of Baricitinib in P-III COV-BARRIER Study for Hospitalized Patients with COVID-19

  • April 8, 2021
Eli Lilly and Incyte's Olumiant + Gilead's Veklury Reduce Time to Recovery in Hospitalized Patients with COVID-19

Eli Lilly and Incyte's Olumiant + Gilead's Veklury Reduce Time to Recovery in Hospitalized Patients with COVID-19

  • September 15, 2020
Glenmark to Initiate P-III Clinical Study Evaluating the Combination Therapy for Hospitalized Patients with COVID-19 in India

Glenmark to Initiate P-III Clinical Study Evaluating the Combination Therapy for Hospitalized Patients with COVID-19 in India

  • May 27, 2020
Abbott's Freestyle Libre System Receives Health Canada Authorization Under Interim Order for Hospitalized Patients During COVID-19

Abbott's Freestyle Libre System Receives Health Canada Authorization Under Interim Order for Hospitalized Patients During COVID-19

  • April 28, 2020
Regeneron and Sanofi Provide Update of P-II/III Adaptive-Designed Trial of Kevzara in Hospitalized Patients with COVID-19 in the US

Regeneron and Sanofi Provide Update of P-II/III Adaptive-Designed Trial of Kevzara in Hospitalized Patients with COVID-19 in the U...

  • April 27, 2020
Alexion to Initiate P-III Study of Ultomiris (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19

Alexion to Initiate P-III Study of Ultomiris (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19

  • April 20, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.